CN101062339A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN101062339A CN101062339A CNA2007101093249A CN200710109324A CN101062339A CN 101062339 A CN101062339 A CN 101062339A CN A2007101093249 A CNA2007101093249 A CN A2007101093249A CN 200710109324 A CN200710109324 A CN 200710109324A CN 101062339 A CN101062339 A CN 101062339A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- diabetes
- following component
- weight proportion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating diabetes, which is prepared from the following constituents (by weigh portions): ginseng 5-10, astragalus root 30-50, white atractylodes rhizome 10-15, poria cocos wolf 10-20, Chinese yam 15-30, pulp of dogwood fruit 15-30, root of balloonflower 10-15, root of herbaceous peony 15-20, wolfberry fruit 10-20, seed of Job's tears 20-30, gorgon euryale seed 10-20, polyporus umbellatus 10-20, saffron 3-5, notoginseng 3-5, radix salvia miltiorrhiza 10-20, American ginseng 5-10 and sea cucumber 20-50.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of diabetes, more specifically to being the Chinese medicine preparation that raw material is made with the Chinese herbal medicine.
Background technology
Diabetes are a kind of common frdquently encountered diseases that are detrimental to health, diabetics surpasses 100,000,000 people in the world at present, and because diabetes do not heal all the life, complication extensively and seriously, case fatality rate is only second to malignant tumor and cardiovascular diseases, so this disease is considered as the 3rd killer of harm humans health by World Health Organization (WHO).
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of diabetes, this medicine has significant curative effect to the treatment diabetes.
The purpose of invention is achieved through the following technical solutions: a kind of medicine for the treatment of diabetes, and at general diabetics, the medicament that adopts following component and weight proportion to make:
Radix Ginseng 5-10 Radix Astragali 30-50 Rhizoma Atractylodis Macrocephalae (parched) 10-15 Poria 10-20 Rhizoma Dioscoreae 15-30 mountain old man's meat 15-30 Radix Platycodonis 10-15 Radix Paeoniae Alba 15-20 Fructus Lycii 10-20 Semen Coicis 20-30 Semen Euryales 10-20 Polyporus 10-20 Stigma Croci sativi 3-5 XUESANQI 3-5 Radix Salviae Miltiorrhizae 10-20 Radix Panacis Quinquefolii 5-10 Stichopus japonicus (processed) dry product 20-50
Above prescription can be according to patient's body constitution and sick time length,, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs medication, plus-minus treatment.If patient's blood fat height then adds medical materials such as Fructus Crataegi, the Radix Polygoni Multiflori, generally adopt Fructus Crataegi 15-20, Radix Polygoni Multiflori 15-20; If patient is the high and concurrent cataract of blood fat then add Flos Chrysanthemi 10-20 again, Semen Cassiae 5-15 not only; After above-mentioned medical material grinding, decoct down at 80-120 ℃, concentrate, grind powder after the oven dry, by sterilization treatment, vacuum packaging can be made into said dosage form on any pharmaceuticss such as pill, powder, electuary.
Have following beneficial effect after diabetics of the present invention is taken: 1, QI invigorating, enrich blood, tonifying the spleen and stomach, the YIN nourishing tonifying the lung; 2, nourishing the liver and kidney, the diuretic dehumidifying; 3 activating blood circulation to dissipate blood stasis, removing pathogenic heat from blood and toxic substance from the body; 4, soothing the liver toxin expelling, blood fat reducing, blood sugar lowering, uric acid resisting, glucose in urine, repairing islet cells, repairing pancreas function, blood glucose, glucose in urine descend, and the back is stable does not rebound.
The present invention be secret prescription handed down in the family from generation to generation in conjunction with modern medicine, select various rare medicinal herbss such as natural Chinese medicinal herb, animal drugs for use, through twenties years pharmacological evaluation, repeatedly practise demonstration, after 3000 many cases diabeticss use, evident in efficacy, it is few to send out money, and instant effect is subjected to patient's favorable comment deeply!
The specific embodiment
Embodiment 1: at weak diabetics, adopt following component and weight proportion (gram):
Radix Ginseng 5 Radix Astragali 30 Rhizoma Atractylodis Macrocephalae (parched)s 10 Poria 10 Rhizoma Dioscoreaes 15 mountain old man's meat 15 Radix Platycodoniss 10 Radix Paeoniae Albas 15 Fructus Lyciis 10 Semen Coiciss 20 Semen Euryaless 10 Polyporus 10 Stigma Croci sativi 3 XUESANQI 3 Radix Salviae Miltiorrhizaes 10 Radix Panacis Quinquefolii 5 Stichopus japonicus (processed) dry products 20
After above-mentioned medical material grinding, decoct down at 80-120 ℃, concentrate, grind powder after the oven dry, by sterilization treatment, vacuum packaging can be made into said dosage form on any pharmaceuticss such as pill, powder, electuary.
Embodiment 2: at blood fat is high but not concurrent cataractous diabetics adopts following component and weight proportion (gram):
Radix Ginseng 10 Radix Astragali 50 Rhizoma Atractylodis Macrocephalae (parched)s 15 Poria 20 Rhizoma Dioscoreaes 20 mountain old man's meat 20 Radix Platycodoniss 15 Radix Paeoniae Albas 20 Fructus Lyciis 20 Semen Coiciss 30 Semen Euryaless 20 Polyporus 20 Stigma Croci sativi 5 XUESANQI 5 Radix Salviae Miltiorrhizaes 20 Radix Panacis Quinquefolii 10 Stichopus japonicus (processed) dry products 50 Fructus Crataegis 20 Radixs Polygoni Multiflori 20
After above-mentioned medical material grinding, decoct down at 80-120 ℃, concentrate, grind powder after the oven dry, by sterilization treatment, vacuum packaging can be made into said dosage form on any pharmaceuticss such as pill, powder, electuary.
Embodiment 3: the high and concurrent cataractous diabetics at blood fat, adopt following component and weight proportion (gram):
Radix Ginseng 10 Radix Astragali 50 Rhizoma Atractylodis Macrocephalae (parched)s 15 Poria 20 Rhizoma Dioscoreaes 20 mountain old man's meat 20 Radix Platycodoniss 15 Radix Paeoniae Albas 20 Fructus Lyciis 20 Semen Coiciss 30 Semen Euryaless 20 Polyporus 20 Stigma Croci sativi 5 XUESANQI 5 Radix Salviae Miltiorrhizaes 20 Radix Panacis Quinquefolii 10 Stichopus japonicus (processed) dry products 50 Fructus Crataegis 20 Radixs Polygoni Multiflori 20 Flos Chrysanthemis 20 Semen Cassiaes 15
After above-mentioned medical material grinding, decoct down at 80-120 ℃, concentrate, grind powder after the oven dry, by sterilization treatment, vacuum packaging can be made into said dosage form on any pharmaceuticss such as pill, powder, electuary.
Claims (4)
1, a kind of medicine for the treatment of diabetes is characterized in that it comprises the medicament that following component and weight proportion are made:
Radix Ginseng 5-10 Radix Astragali 30-50 Rhizoma Atractylodis Macrocephalae (parched) 10-15
Poria 10-20 Rhizoma Dioscoreae 15-30 mountain old man's meat 15-30
Radix Platycodonis 10-15 Radix Paeoniae Alba 15-20 Fructus Lycii 10-20
Semen Coicis 20-30 Semen Euryales 10-20 Polyporus 10-20
Stigma Croci sativi 3-5 XUESANQI 3-5 Radix Salviae Miltiorrhizae 10-20
Radix Panacis Quinquefolii 5-10 Stichopus japonicus (processed) dry product 20-50
2, the medicine of the described treatment diabetes of claim 1 is characterized in that it also comprises following component and weight proportion:
Fructus Crataegi 15-20 Radix Polygoni Multiflori 15-20
3, the medicine of the described treatment diabetes of claim 2 is characterized in that it also comprises following component and weight proportion:
Flos Chrysanthemi 10-20 Semen Cassiae 5-15
4, the medicine of the described treatment diabetes of claim 1 is characterized in that said medicament is a said dosage form on any pharmaceutics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101093249A CN101062339A (en) | 2007-05-23 | 2007-05-23 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101093249A CN101062339A (en) | 2007-05-23 | 2007-05-23 | Medicine for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101062339A true CN101062339A (en) | 2007-10-31 |
Family
ID=38963756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101093249A Pending CN101062339A (en) | 2007-05-23 | 2007-05-23 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101062339A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2483121A (en) * | 2010-08-27 | 2012-02-29 | Persavita Ltd | Composition comprising resveratrol and saffron |
| WO2012025229A1 (en) | 2010-08-27 | 2012-03-01 | Persavita Ltd. | Composition and method of manufacture |
| CN103497875A (en) * | 2013-09-28 | 2014-01-08 | 武汉正立源科技有限公司 | Health care medicinal liquor |
| CN103495115A (en) * | 2013-09-28 | 2014-01-08 | 武汉正立源科技有限公司 | Medicinal liquor |
| EP2514432A4 (en) * | 2010-12-14 | 2014-07-09 | Dalian Haiyantang Biology Co | Sea cucumber compound preparation and preparation method thereof |
| CN104116885A (en) * | 2014-08-06 | 2014-10-29 | 武小力 | Composition for assisting hyperglycemic capsules and preparation method thereof |
| CN107518384A (en) * | 2016-06-22 | 2017-12-29 | 江西江中食疗科技有限公司 | A kind of composition and preparation method thereof |
-
2007
- 2007-05-23 CN CNA2007101093249A patent/CN101062339A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2483121A (en) * | 2010-08-27 | 2012-02-29 | Persavita Ltd | Composition comprising resveratrol and saffron |
| WO2012025229A1 (en) | 2010-08-27 | 2012-03-01 | Persavita Ltd. | Composition and method of manufacture |
| US9486464B2 (en) | 2010-08-27 | 2016-11-08 | Persavita Ltd | Composition and method of manufacture |
| EP2514432A4 (en) * | 2010-12-14 | 2014-07-09 | Dalian Haiyantang Biology Co | Sea cucumber compound preparation and preparation method thereof |
| CN103497875A (en) * | 2013-09-28 | 2014-01-08 | 武汉正立源科技有限公司 | Health care medicinal liquor |
| CN103495115A (en) * | 2013-09-28 | 2014-01-08 | 武汉正立源科技有限公司 | Medicinal liquor |
| CN103495115B (en) * | 2013-09-28 | 2015-09-30 | 武汉正立源科技有限公司 | A kind of to the medicative medicated wine of diabetes tool |
| CN103497875B (en) * | 2013-09-28 | 2016-03-02 | 牛正华 | A kind of to the medicative protective foods wine of diabetes tool |
| CN104116885A (en) * | 2014-08-06 | 2014-10-29 | 武小力 | Composition for assisting hyperglycemic capsules and preparation method thereof |
| CN107518384A (en) * | 2016-06-22 | 2017-12-29 | 江西江中食疗科技有限公司 | A kind of composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062339A (en) | Medicine for treating diabetes | |
| CN1305483C (en) | Heart failure regulating Chinese medicine | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN103330826A (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN101095768A (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN101856487A (en) | Chinese medicament for treating insomnia | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN105796845A (en) | Application of medicine composition in preparing medicine for treating female climacteric syndromes | |
| CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN104257839B (en) | A kind of Chinese medicine composition with hypoglycemic protection blood vessel endothelium effect and preparation method thereof | |
| CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
| CN101843778B (en) | Chinese medicament for treating ichthyosis | |
| CN101491612A (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN101199667A (en) | Chinese medicine for treating leukemia, aplastic anemia | |
| CN102266540B (en) | Chinese medicament for treating constipation | |
| CN103028076A (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
| CN101829213B (en) | Medicine composition for treating asthma and preparation method thereof | |
| CN114617934B (en) | Detoxifying and whitening soup | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101987188A (en) | Biological Chinese patent drug for preventing and treating hyperlipoidemia | |
| CN101264208A (en) | Medicinal composition for treating stomach and intestine dysfunction and preparation thereof | |
| CN1124851C (en) | Chinese patent medicine (Tangshenkang) for treating diabetes and nephrosis and its preparing process | |
| CN1167432C (en) | Hypoglycemic life-elongating tablet and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071031 |